The weight-loss drug Zepbound was linked to a reduction in obstructive sleep apnea (OSA), according to new research. Pharmaceutical manufacturer Eli Lilly on Wednesday said injections of its obesity ...

If you've been diagnosed with sleep apnea, you likely already know that a continuous positive airway pressure (CPAP) device ...

People with obesity who received the weight-loss drug Zepbound had fewer obstructive sleep apnea events, or episodes of stopped breathing during sleep. The research by drug maker Eli Lilly included ...

Millions of people in the U.S. have sleep apnea, most of whom aren’t getting treated for it. But a simple daily pill of an ...

The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep apnea, or OSA, which refers to breathing interrupted during sleep ...

Continuous positive airway pressure (CPAP) is the standard treatment for treating obstructive sleep apnea (OSA), but clinicians should remember that weight loss is also an effective approach for ...

Adequate sleep (about seven to eight hours for adults) is crucial to your health, alertness and more. Obstructive sleep apnea ...

For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has ...

If sleep apnea is left untreated, one becomes vulnerable to many lifestyle ailments like diabetes and hypertension.

A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.